BridgeMD
New treatment option for COPD
Official title Effect of Breather in COPD Patients With Intermittent Claudication
ClinicalTrials.gov ID: NCT06529185
What this study is testing
What is pharmacological treatment?
pharmacological treatment is an investigational medicine, being studied as a potential treatment for copd.
Also referred to as control group.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- The aim of this study To show the effect of breather on ventilatory and vascular function in COPD patient with intermittent claudication.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 50 to 60, men only
You may be able to join if
- sixty male patients with diagnosed with grade I and grade II COPD their ages ranged between 55-60years
- All patients will be clinically and medically stable when attending the study.
- Body mass index (BMI) is 18.5 to 24.9 kg/m2.
- History of unilateral exertional leg pain,
- Ambulation during a graded treadmill test limited by leg pain consistent with intermittent claudication (stage II of the fontaine classification of...
You likely can't join if
- cardiovascular insufficiency,
- Recent myocardial infarction,
- heart failure,
- arrhythmia,
- DVT,
- Intracranial hypertension,
See the full eligibility criteria
- sixty male patients with diagnosed with grade I and grade II COPD their ages ranged between 55-60years
- All patients will be clinically and medically stable when attending the study.
- Body mass index (BMI) is 18.5 to 24.9 kg/m2.
- History of unilateral exertional leg pain,
- Ambulation during a graded treadmill test limited by leg pain consistent with intermittent claudication (stage II of the fontaine classification of pad),
- And an ankle-brachial index (ABI) of 0.90 or lower at rest or 0.73 or lower after exercise.
- cardiovascular insufficiency,
- Recent myocardial infarction,
- heart failure,
- arrhythmia,
- DVT,
- Intracranial hypertension,
- Pneumonia,
- kidney failure,
- fractures,
- uncooperative patients,
- cognitive impairment preventing a patient from participation in exercises.
The study team makes the final eligibility decision.
Where it's taking place
- Dokki, Egypt
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling male, 50 years to 60 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Dokki, Egypt. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.